Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
48.74
-0.38 (-0.77%)
At close: Feb 11, 2026, 4:00 PM EST
48.86
+0.12 (0.25%)
After-hours: Feb 11, 2026, 7:59 PM EST
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Sep 30, 2025 | 33.92B | 12.87B | 3.16B |
| Jun 30, 2025 | 33.73B | 12.50B | 3.14B |
| Mar 31, 2025 | 33.51B | 11.48B | 2.99B |
| Dec 31, 2024 | 32.70B | 10.31B | 2.95B |
| Sep 30, 2024 | 31.36B | 8.70B | 2.77B |
| Jun 30, 2024 | 30.51B | 7.66B | 2.66B |
| Mar 31, 2024 | 28.88B | 7.09B | 2.69B |
| Dec 31, 2023 | 27.46B | 6.59B | 2.72B |
| Sep 30, 2023 | 25.51B | 5.68B | 2.76B |
| Jun 30, 2023 | 24.49B | 4.43B | 2.95B |
| Mar 31, 2023 | 23.30B | 3.37B | 3.13B |
| Dec 31, 2022 | 22.09B | 2.67B | 3.25B |
| Sep 30, 2022 | 21.04B | 2.19B | 3.23B |
| Jun 30, 2022 | 19.87B | 1.88B | 3.13B |
| Mar 31, 2022 | 18.86B | 1.62B | 3.10B |
| Dec 31, 2021 | 17.92B | 1.33B | 3.04B |
| Sep 30, 2021 | 16.72B | 1.13B | 3.00B |
| Jun 30, 2021 | 15.94B | 983.84M | 3.05B |
| Mar 31, 2021 | 15.62B | 896.79M | 3.02B |
| Dec 31, 2020 | 15.38B | 898.84M | 3.04B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.